TY - JOUR
T1 - Long-term prognosis analysis of surgical therapy for bilateral synchronous multiple primary lung cancer
T2 - a follow-up of 293 cases
AU - Zhang, Hui
AU - Chen, Lian
AU - Mao, Feng
AU - Li, Jiantiao
AU - Hamaji, Masatsugu
AU - Shimada, Yoshihisa
AU - Koo, Chi Wan
AU - Song, Zuodong
AU - Song, Liwei
AU - Lu, Shun
N1 - Publisher Copyright:
© Journal of Thoracic Disease. All rights reserved.
PY - 2024/2
Y1 - 2024/2
N2 - Background: Bilateral synchronous multiple primary lung cancer (BSMPLC) presents significant clinical challenges due to its unique characteristics and prognosis. Understanding the risk factors that influence overall survival (OS) and recurrence-free survival (RFS) is crucial for optimizing therapeutic strategies for BSMPLC patients. Methods: We retrospectively analyzed clinical characteristics and treatment outcomes of 293 patients with BSMPLC who underwent surgical treatment between January 2010 and July 2017. Results: The 10-year OS and RFS rates were 96.1% and 92.8%, respectively. Preoperative forced expiratory volume in 1 second (FEV1) ≥70% [hazard ratio (HR), 0.214; 95% confidence interval (CI): 0.053 to 0.857], identical pathology types (HR, 9.726; 95% CI: 1.886 to 50.151), largest pT1 (HR, 7.123; 95% CI: 2.663 to 19.055), and absence of lymphovascular invasion (LVI; HR, 7.021; 95% CI: 1.448 to 34.032) emerged as independent predictors of improved OS. Moreover, the sum of tumor sizes less than or equal to 3 cm (HR, 6.229; 95% CI: 1.411 to 27.502) and absence of pleural invasion (HR, 3.442; 95% CI: 1.352 to 8.759) were identified as independent predictors of enhanced RFS. The presence or absence of residual nodules after bilateral surgery did not influence patients’ OS (P=0.987) and RFS (P=0.054). Conclusions: Patients with BSMPLC who underwent surgery generally had a favorable prognosis.
AB - Background: Bilateral synchronous multiple primary lung cancer (BSMPLC) presents significant clinical challenges due to its unique characteristics and prognosis. Understanding the risk factors that influence overall survival (OS) and recurrence-free survival (RFS) is crucial for optimizing therapeutic strategies for BSMPLC patients. Methods: We retrospectively analyzed clinical characteristics and treatment outcomes of 293 patients with BSMPLC who underwent surgical treatment between January 2010 and July 2017. Results: The 10-year OS and RFS rates were 96.1% and 92.8%, respectively. Preoperative forced expiratory volume in 1 second (FEV1) ≥70% [hazard ratio (HR), 0.214; 95% confidence interval (CI): 0.053 to 0.857], identical pathology types (HR, 9.726; 95% CI: 1.886 to 50.151), largest pT1 (HR, 7.123; 95% CI: 2.663 to 19.055), and absence of lymphovascular invasion (LVI; HR, 7.021; 95% CI: 1.448 to 34.032) emerged as independent predictors of improved OS. Moreover, the sum of tumor sizes less than or equal to 3 cm (HR, 6.229; 95% CI: 1.411 to 27.502) and absence of pleural invasion (HR, 3.442; 95% CI: 1.352 to 8.759) were identified as independent predictors of enhanced RFS. The presence or absence of residual nodules after bilateral surgery did not influence patients’ OS (P=0.987) and RFS (P=0.054). Conclusions: Patients with BSMPLC who underwent surgery generally had a favorable prognosis.
KW - Synchronous multiple primary lung cancer (SMPLC)
KW - overall survival (OS)
KW - recurrence-free survival (RFS)
KW - surgical therapy
UR - http://www.scopus.com/inward/record.url?scp=85186632450&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85186632450&partnerID=8YFLogxK
U2 - 10.21037/jtd-23-1940
DO - 10.21037/jtd-23-1940
M3 - Article
AN - SCOPUS:85186632450
SN - 2072-1439
VL - 16
SP - 1450
EP - 1462
JO - Journal of Thoracic Disease
JF - Journal of Thoracic Disease
IS - 2
ER -